Article Text

Download PDFPDF
Sexualised drug use in people attending sexual health clinics in England
  1. Hamish Mohammed1,
  2. John Were1,
  3. Carina King1,2,
  4. Martina Furegato1,
  5. Anthony Nardone1,
  6. Gwenda Hughes1
  7. on behalf of the GUMCADv3 Steering Group
    1. 1 HIV & STI Department, Public Health England, London, UK
    2. 2 Research Department of Infection and Population Health, University College London, London, UK
    1. Correspondence to Dr Hamish Mohammed, Principal STI Prevention & Surveillance Scientist, HIV & STI Department, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK; hamish.mohammed{at}

    Statistics from

    Recent evidence highlights an increase in ‘chemsex’, the use of recreational drugs during sex, in men who have sex with men (MSM) and an association with risky sexual behaviours and outbreaks of STIs.1 However, the extent of sexualised drug use in people attending sexual health clinics (SHCs) is unknown.

    STI surveillance in England is performed by Public Health England (PHE) using a disaggregated patient-level dataset of all diagnoses and services at SHCs.2 This is a minimum dataset with key demographic and clinical variables, but lacks behavioural data. To address this gap, PHE …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.